InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced new in vitro findings demonstrating that izicopan ...
This new Aramchol formulation was co-developed by Galmed and Barcode Nanotech, based on Barcode Nanotech's unique and proprietary platform which enables simultaneous screening of hundreds of different ...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that data ...
Company to showcase expansion opportunity for EVO756 (MRGPRX2 Antagonist) into third indication of migraine prophylaxis; ...
Rigel Pharmaceuticals' Gavreto acquisition materially boosted revenue and is valued at ~$245M NPV, about half of RIGL's ...
KT-200 is a first-in-class, oral CDK2 molecular glue degrader development candidate Option exercise of KT-200 triggers a $45 million milestone ...
NovaBridge Biosciences remains a high-risk, catalyst-driven biotech, trading near cash value with a focus on pipeline ...
Omeros Corporation (NASDAQ:OMER) Q4 2025 Earnings Call Transcript April 1, 2026 Operator: Good afternoon, and welcome to today’s earnings call for Omeros Corporation. [Operator Instructions] Please be ...
On 30 March, 2026, Abbisko Therapeutics Co., Ltd. (Abbisko Therapeutics hereafter, HKEX code: 02256.HK) announced that the ...
March 2026, Abbisko Therapeutics Co., Ltd. (Abbisko Therapeutics hereafter, HKEX code: 02256) announced that its ...
The new musical is trying to calibrate just how much to rein in the audience participation that longtime fans are used to.
The small molecule could slow or stop the progression of Parkinson’s disease and related brain disorders, rather than just treating symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results